GlaxoSmithKline logo

GSK - GlaxoSmithKline Share Price

1489.4p -3.8  -0.3%

Last Trade - 03/04/20

Large Cap
Market Cap £74.72bn
Enterprise Value £107.40bn
Revenue £33.75bn
Position in Universe 10th / 1834
Unlock GSK Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


GSK Revenue Unlock GSK Revenue

Net Income

GSK Net Income Unlock GSK Revenue

Normalised EPS

GSK Normalised EPS Unlock GSK Revenue

PE Ratio Range

GSK PE Ratio Range Unlock GSK Revenue

Dividend Yield Range

GSK Dividend Yield Range Unlock GSK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GSK EPS Forecasts Unlock GSK Revenue
Profile Summary

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.

Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated December 6, 1999
Public Since May 22, 1972
No. of Shareholders: 105,783
No. of Employees: 99,437
GSK Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for GSK
Upcoming Events for GSK
Wednesday 29th April, 2020 Estimate
Q1 2020 GlaxoSmithKline PLC Earnings Release
Wednesday 6th May, 2020
GlaxoSmithKline PLC Annual Shareholders Meeting
Thursday 7th May, 2020 Estimate
GlaxoSmithKline PLC Annual Shareholders Meeting
Wednesday 29th July, 2020
Q2 2020 GlaxoSmithKline PLC Earnings Release
Similar to GSK
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.